Cargando…

Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography

Women from breast cancer families without a demonstrable BRCA1/2 mutation were subjected to annual mammography from age 30 years onwards. One-hundred and ninety-eight patients were diagnosed prospectively with invasive breast cancer and followed for a total of 1513 years. Overall 10-year survival wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Møller, Pål, Tharmaratnam, Kukatharmini, Howell, Anthony, Stavrinos, Paula, Sampson, Sarah, Wallace, Andrew, Maxwell, Anthony J., Hagen, Anne Irene, Evans, D. Gareth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2015
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468806/ https://www.ncbi.nlm.nih.gov/pubmed/26037256 http://dx.doi.org/10.1007/s10549-015-3448-6

Ejemplares similares

MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis
por: Tharmaratnam, Kukatharmini, et al.
Publicado: (2014)

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
por: Evans, D. Gareth R., et al.
Publicado: (2019)

Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women
por: Evans, D. Gareth, et al.
Publicado: (2021)

Ten modifiers of BRCA1 penetrance validated in a Norwegian series
por: Heramb, Cecilie, et al.
Publicado: (2015)

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation
por: Møller, Pål, et al.
Publicado: (2014)

Psychological impact of providing women with personalised 10-year breast cancer risk estimates
por: French, David P., et al.
Publicado: (2018)

Local staging of ipsilateral breast tumor recurrence: mammography, ultrasound, or MRI?
por: Walstra, Coco J. E. F., et al.
Publicado: (2020)

The value of mammography in women with focal breast complaints in addition to initial targeted ultrasound
por: Appelman, L., et al.
Publicado: (2020)

Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA
por: Bradley, Patrick, et al.
Publicado: (2020)

Tilting the lasso by knowledge-based post-processing
por: Tharmaratnam, Kukatharmini, et al.
Publicado: (2016)

Acceptability of a companion patient guide to support expert consensus guidelines on surveillance mammography in older breast cancer survivors
por: Freedman, Rachel A., et al.
Publicado: (2022)

Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach
por: Tan, Wei Shen, et al.
Publicado: (2020)

Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UK
por: Evans, D. Gareth, et al.
Publicado: (2018)

Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study
por: Bozzini, Anna, et al.
Publicado: (2020)

Breast mammography and tumour volume.
por: Robertson, J. F., et al.
Publicado: (1987)

57437 Effects of Prebiotics on the Gut Microbiome Profile, Beta-cell Function and Immune Markers in Newly-Diagnosed Type 1 Diabetes
por: Ismail, Heba M., et al.
Publicado: (2021)

Microscopic Tumour Classification by Digital Mammography
por: Yang, Jingjing, et al.
Publicado: (2021)

Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study
por: Harvey, James R., et al.
Publicado: (2018)

FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment
por: Wilkins, Anna, et al.
Publicado: (2018)

Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality
por: Evans, D. G., et al.
Publicado: (2016)

Retracted: Microscopic Tumour Classification by Digital Mammography
por: Healthcare Engineering, Journal of
Publicado: (2023)

Mammography as a method for diagnosing breast cancer
por: Koch, Hilton
Publicado: (2016)

Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana
por: Vriesendorp, Reinout, et al.
Publicado: (2007)

Serum heparan sulfate and chondroitin sulfate concentrations in patients with newly diagnosed exfoliative glaucoma
por: Maric, Vesna D., et al.
Publicado: (2019)

2224: Characterizing vigilant thoughts and behaviors that disrupt sleep in veterans and utilization of cognitive techniques
por: Katherine Howell, Mary, et al.
Publicado: (2018)

CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis
por: Behrouzi, Roya, et al.
Publicado: (2023)

An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subjects
por: Round, Patrick, et al.
Publicado: (2011)

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2017)

Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients
por: Nteliopoulos, Georgios, et al.
Publicado: (2021)

Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP)
por: Howell, Sacha J., et al.
Publicado: (2020)

The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2022)

Pre-operative stromal stiffness measured by shear wave elastography is independently associated with breast cancer-specific survival
por: Evans, Andy, et al.
Publicado: (2018)

Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?
por: Gareth Evans, D, et al.
Publicado: (2004)

Can the breast screening appointment be used to provide risk assessment and prevention advice?
por: Evans, D. Gareth, et al.
Publicado: (2015)

A systematic review of pediatric clinical trials of high dose vitamin D
por: Nama, Nassr, et al.
Publicado: (2016)

Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer
por: Davidson, Michael, et al.
Publicado: (2017)

Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer
por: Coe, Faye, et al.
Publicado: (2021)

Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer
por: Elliott, Daisy, et al.
Publicado: (2018)

CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer
por: Mostafid, A. Hugh, et al.
Publicado: (2020)

The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression
por: Bryant, Richard J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8qocacjdsfn3dbi779otgst5cb